News
U.S. stocks remained lower in final hour of trading on Tuesday, as investors turned cautious ahead of the Federal Reserve's ...
The S&P 500 slipped 0.4% and is on track for a third straight modest loss after setting its all-time high last week. The Dow ...
U.S. stocks closed a listless day nearly flat as investors wait for key retail earnings and an annual Fed conference for ...
Chinese bank stocks are poised to rise in the second half, attracting dividend-seeking investors as the sector benefits from ...
The stock closed nearly 7% higher Tuesday after Japan’s SoftBank (JP:9984) agreed to invest $2 billion in ...
As the summer doldrums set in, highflying sectors like technology may finally be due for a breather. The healthcare sector ...
Crypto stocks suffered Tuesday as investors fled tech stocks and riskier corners of the market. Among crypto exchanges, ...
The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.
Nvidia, the chips group that has surged to become the world’s first $4tn company on the back of AI, fell 3.5 per cent on ...
Mike Wilson, Morgan Stanley chief U.S. equity strategist, joins 'Power Lunch' to discuss what could be coming for equity ...
At the beginning of the year I targeted Amazon's stock price at $270/share by the year-end, driven by fundamental improvement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results